Wall Street Zen cut shares of Editas Medicine (NASDAQ:EDIT – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday. Several other equities research analysts also recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Editas Medicine in a [...]
Editas Medicine (NASDAQ:EDIT) Lowered to “Sell” Rating by Wall Street Zen
